A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic Arthritis
Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if Infliximab is safe and effective in the
treatment of psoriatic arthritis. Infliximab (Remicade) targets specific proteins in the
body's immune system to help control the development of inflammation to help reduce painful
disease.